Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Jagar Jasem

The 21-Gene Recurrence Score Assay for Node-Positive, Early-Stage Breast Cancer and Impact of RxPONDER Trial on Chemotherapy Decision-Making: Have Clinicians Already Decided?

Journal of the National Comprehensive Cancer Network : JNCCN

Medicine

Oncology

2017

English

Outcomes of Patients With Central Nervous System Complications After Allogeneic Hematopoietic Stem Cell Transplantation

Biology of Blood and Marrow Transplantation

Transplantation

Hematology

2013

English

Related publications

21-Gene Recurrence Score Decreases Receipt of Chemotherapy in ER+ Early-Stage Breast Cancer: An Analysis of the NCDB 2010–2013

Breast Cancer Research and Treatment

Cancer Research

Oncology

2016

English

Cost-Effectiveness Analysis of Recurrence Score-Guided Treatment Using a 21-Gene Assay in Early Breast Cancer

English

Association Between the 21-Gene Recurrence Score and Isolated Local-Regional Recurrence in Hormone Receptor-Positive Breast Cancer

International Journal of Radiation Oncology Biology Physics

English

Distribution Patterns of 21-Gene Recurrence Score in 980 Chinese Estrogen Receptor-Positive, HER2-negative Early Breast Cancer Patients

Oncotarget

Oncology

2017

English

Comparison of the Prognostic and Predictive Utilities of the 21-Gene Recurrence Score Assay and Adjuvant! For Women With Node-Negative, ER-positive Breast Cancer: Results From NSABP B-14 and NSABP B-20

Breast Cancer Research and Treatment

Cancer Research

Oncology

2011

English

Lymph Node Involvement: Positive About the Role of the Recurrence Score in Estrogen-Driven Breast Cancer?

English

Evaluating the 21-Gene Assay Recurrence Score® as a Predictor of Clinical Response to 24 Weeks of Neoadjuvant Exemestane in Estrogen Receptor-Positive Breast Cancer

International Journal of Clinical Oncology

English

Randomised Trial: Survival Benefit and Safety of Adjuvant Dose-Dense Chemotherapy for Node-Positive Breast Cancer

British Journal of Cancer

Cancer Research

Oncology

2006

English

Quantitative Gene Expression by Recurrence Score in ER-Positive Breast Cancer, by Age

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Jagar Jasem

The 21-Gene Recurrence Score Assay for Node-Positive, Early-Stage Breast Cancer and Impact of RxPONDER Trial on Chemotherapy Decision-Making: Have Clinicians Already Decided?

Outcomes of Patients With Central Nervous System Complications After Allogeneic Hematopoietic Stem Cell Transplantation

Related publications

21-Gene Recurrence Score Decreases Receipt of Chemotherapy in ER+ Early-Stage Breast Cancer: An Analysis of the NCDB 2010–2013

Cost-Effectiveness Analysis of Recurrence Score-Guided Treatment Using a 21-Gene Assay in Early Breast Cancer

Association Between the 21-Gene Recurrence Score and Isolated Local-Regional Recurrence in Hormone Receptor-Positive Breast Cancer

Distribution Patterns of 21-Gene Recurrence Score in 980 Chinese Estrogen Receptor-Positive, HER2-negative Early Breast Cancer Patients

Comparison of the Prognostic and Predictive Utilities of the 21-Gene Recurrence Score Assay and Adjuvant! For Women With Node-Negative, ER-positive Breast Cancer: Results From NSABP B-14 and NSABP B-20

Lymph Node Involvement: Positive About the Role of the Recurrence Score in Estrogen-Driven Breast Cancer?

Evaluating the 21-Gene Assay Recurrence Score® as a Predictor of Clinical Response to 24 Weeks of Neoadjuvant Exemestane in Estrogen Receptor-Positive Breast Cancer

Randomised Trial: Survival Benefit and Safety of Adjuvant Dose-Dense Chemotherapy for Node-Positive Breast Cancer

Quantitative Gene Expression by Recurrence Score in ER-Positive Breast Cancer, by Age